secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0000805928-22-000110
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axogen appoints Adrian Tyndall to board; founding director Mark Gold retires Dec 13
--------------------------------------------------------------------------------

- Founding director Dr. Mark Gold resigns effective Dec 13, 2022; no dispute cited.
- Dr. Adrian Tyndall appointed to board effective Dec 13; will serve on Quality, Compliance & Portfolio Committee.
- Tyndall is Exec VP for Health Affairs & Dean of Morehouse School of Medicine; former UF College of Medicine interim dean.
- Tyndall receives standard director compensation: $10k quarterly cash retainer, $1.25k committee retainer, $275k initial option grant vesting over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000080592822000110/0000805928-22-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000080592822000110/axgn-20221025.htm
  HTML page:      https://secwatch.observer/filing/0000805928-22-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer